SI2802624T1 - Modified collagen - Google Patents

Modified collagen Download PDF

Info

Publication number
SI2802624T1
SI2802624T1 SI201330815T SI201330815T SI2802624T1 SI 2802624 T1 SI2802624 T1 SI 2802624T1 SI 201330815 T SI201330815 T SI 201330815T SI 201330815 T SI201330815 T SI 201330815T SI 2802624 T1 SI2802624 T1 SI 2802624T1
Authority
SI
Slovenia
Prior art keywords
collagen
temperature
modified
step comprises
dehydration
Prior art date
Application number
SI201330815T
Other languages
English (en)
Slovenian (sl)
Inventor
Alexandra Dietrich
Michael Myers
Original Assignee
Innocoll Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20120150527 external-priority patent/EP2612888A1/en
Priority claimed from GBGB1220868.2A external-priority patent/GB201220868D0/en
Application filed by Innocoll Pharmaceuticals Limited filed Critical Innocoll Pharmaceuticals Limited
Publication of SI2802624T1 publication Critical patent/SI2802624T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI201330815T 2012-01-09 2013-01-09 Modified collagen SI2802624T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP20120150527 EP2612888A1 (en) 2012-01-09 2012-01-09 A modified collagen
GBGB1220868.2A GB201220868D0 (en) 2012-11-20 2012-11-20 A modified collagen
PCT/EP2013/050333 WO2013104687A2 (en) 2012-01-09 2013-01-09 A modified collagen
EP13700286.1A EP2802624B1 (en) 2012-01-09 2013-01-09 A modified collagen

Publications (1)

Publication Number Publication Date
SI2802624T1 true SI2802624T1 (en) 2018-02-28

Family

ID=47559477

Family Applications (3)

Application Number Title Priority Date Filing Date
SI201330815T SI2802624T1 (en) 2012-01-09 2013-01-09 Modified collagen
SI201331458T SI3255106T1 (sl) 2012-01-09 2013-01-09 Modificiran kolagen
SI201331876T SI3536748T1 (sl) 2012-01-09 2013-01-09 Modificiran kolagen

Family Applications After (2)

Application Number Title Priority Date Filing Date
SI201331458T SI3255106T1 (sl) 2012-01-09 2013-01-09 Modificiran kolagen
SI201331876T SI3536748T1 (sl) 2012-01-09 2013-01-09 Modificiran kolagen

Country Status (22)

Country Link
US (4) US10487134B2 (enExample)
EP (4) EP3255106B1 (enExample)
JP (3) JP6494285B2 (enExample)
AU (1) AU2013208952B2 (enExample)
CA (1) CA2860552C (enExample)
CY (3) CY1119524T1 (enExample)
DK (3) DK2802624T3 (enExample)
EA (2) EA037396B1 (enExample)
ES (3) ES2645445T3 (enExample)
HK (1) HK1244296B (enExample)
HR (3) HRP20171635T1 (enExample)
HU (3) HUE037043T2 (enExample)
LT (3) LT2802624T (enExample)
MX (1) MX368037B (enExample)
NO (1) NO2802624T3 (enExample)
PL (3) PL3255106T3 (enExample)
PT (2) PT2802624T (enExample)
RS (3) RS61726B1 (enExample)
SI (3) SI2802624T1 (enExample)
SM (3) SMT202100257T1 (enExample)
TR (1) TR201907156T4 (enExample)
WO (1) WO2013104687A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20171635T1 (hr) * 2012-01-09 2018-02-23 Innocoll Pharmaceuticals Limited Modificirani kolagen
US20180237259A1 (en) * 2017-02-22 2018-08-23 Otis Elevator Company Method for detecting trapped passengers in elevator car
RU2704248C1 (ru) * 2018-10-02 2019-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") Способ получения пористого коллагенового материала
RU2760326C1 (ru) * 2021-03-04 2021-11-24 Общество с ограниченной ответственностью научно-производственное объединение «Велис» Способ получения пористого влагоемкого материала на коллагеновой основе
US20240226382A1 (en) 2021-04-12 2024-07-11 Innocoll Pharmaceuticals Limited Drug-release implant for laparoscopic surgery
CN113201569B (zh) * 2021-06-21 2022-08-30 江南大学 一种牛ⅰ型胶原蛋白的纯化方法
IL310517A (en) * 2021-07-28 2024-03-01 Innocoll Pharm Ltd Bupivacaine-collagen drug delivery implant and methods of making and using thereof
WO2023084005A1 (en) * 2021-11-12 2023-05-19 Innocoll Pharmaceuticals Limited Resorbable collagen scaffold for dural repair
WO2024079289A1 (en) 2022-10-12 2024-04-18 Innocoll Pharmaceuticals Limited A kit for implanting a drug-release implant for laparoscopic surgery
CN115975247B (zh) 2022-12-21 2024-01-30 合肥工业大学 一种抗生物污损的磁性丝素蛋白基复合气凝胶、制备方法及其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246282B2 (enExample) * 1972-11-15 1977-11-24
US4097234A (en) * 1976-12-10 1978-06-27 Nippi, Incorporated Method for preparing dispersion of collagen fiber
US4279812A (en) 1979-09-12 1981-07-21 Seton Company Process for preparing macromolecular biologically active collagen
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
FR2720945B1 (fr) 1994-06-08 1996-08-30 Coletica Membrane collagénique anti-adhérence post-opératoire.
US5945125A (en) 1995-02-28 1999-08-31 Temple University Controlled release tablet
AU716137B2 (en) * 1997-01-16 2000-02-17 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US20010014667A1 (en) * 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6682760B2 (en) * 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
CA2434972C (en) * 2001-01-16 2010-06-08 Vascular Therapies, Llc Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
JP2004099513A (ja) * 2002-09-09 2004-04-02 Toshiba Corp クラゲのコラーゲン回収方法及びクラゲのコラーゲン回収システム
US7396912B2 (en) * 2003-04-11 2008-07-08 Ecodynamic Biolab Collagen production method
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
SI2139457T1 (sl) * 2007-03-28 2016-09-30 Innocoll Pharmaceutical Limited Naprava za dajanje zdravila za zagotavljanje lokalne analgezije, lokalne anestezije ali živčne blokade
USRE47826E1 (en) * 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US8034368B2 (en) * 2007-03-28 2011-10-11 Innocoll Technologies Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US7820794B2 (en) 2008-09-11 2010-10-26 Sunmax Biotechnology Co., Ltd. Long-lasting collagen and manufacturing method thereof
EP2352531A2 (en) * 2008-11-06 2011-08-10 Innocoll Technologies Limited Drug delivery implants and processes for their preparation
WO2011014155A1 (en) 2009-07-27 2011-02-03 National Cheng Kung University Preparation of high purity collagen
JP2011225462A (ja) * 2010-04-16 2011-11-10 Ihara Suisan Kk 多孔質コラーゲン、その製造方法およびその用途
WO2011139228A1 (en) 2010-05-07 2011-11-10 Empire Technology Development Llc Nano scale collagen particles and membranes
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
HRP20171635T1 (hr) * 2012-01-09 2018-02-23 Innocoll Pharmaceuticals Limited Modificirani kolagen
US11623947B2 (en) * 2013-04-08 2023-04-11 Innocoll Pharmaceuticals Limited Collagen powder

Also Published As

Publication number Publication date
JP6494285B2 (ja) 2019-04-03
PL3536748T3 (pl) 2021-07-19
AU2013208952A1 (en) 2014-08-28
RS58935B1 (sr) 2019-08-30
JP2020169188A (ja) 2020-10-15
LT2802624T (lt) 2017-12-27
HUE037043T2 (hu) 2018-08-28
AU2013208952B2 (en) 2016-09-15
PL2802624T3 (pl) 2018-02-28
DK3255106T3 (da) 2019-05-20
SMT202100257T1 (it) 2021-07-12
CY1119524T1 (el) 2018-03-07
EA027745B1 (ru) 2017-08-31
EP3536748B1 (en) 2021-02-24
ES2645445T3 (es) 2017-12-05
US20190359689A1 (en) 2019-11-28
PT3255106T (pt) 2019-06-04
MX2014008327A (es) 2015-05-11
HUE043826T2 (hu) 2019-09-30
SMT201900373T1 (it) 2019-09-09
US20220213173A1 (en) 2022-07-07
EA201790763A3 (ru) 2017-11-30
LT3255106T (lt) 2019-07-25
EP3255106B1 (en) 2019-04-24
HUE054838T2 (hu) 2021-10-28
JP7213205B2 (ja) 2023-01-26
MX368037B (es) 2019-09-17
EP3536748A1 (en) 2019-09-11
SI3536748T1 (sl) 2021-08-31
SMT201700507T1 (it) 2018-01-11
SI3255106T1 (sl) 2019-09-30
HRP20190861T1 (hr) 2019-08-09
DK3536748T3 (da) 2021-05-03
CA2860552A1 (en) 2013-07-18
US11746141B2 (en) 2023-09-05
JP2015508403A (ja) 2015-03-19
EA037396B1 (ru) 2021-03-24
EA201491278A1 (ru) 2015-01-30
EP2802624A2 (en) 2014-11-19
PL3255106T3 (pl) 2019-09-30
CY1121643T1 (el) 2020-07-31
WO2013104687A2 (en) 2013-07-18
WO2013104687A3 (en) 2013-12-05
CA2860552C (en) 2020-06-16
JP6720279B2 (ja) 2020-07-08
TR201907156T4 (tr) 2019-06-21
US10487134B2 (en) 2019-11-26
PT2802624T (pt) 2017-11-10
ES2728205T3 (es) 2019-10-22
EP3255106A1 (en) 2017-12-13
RS61726B1 (sr) 2021-05-31
ES2870137T3 (es) 2021-10-26
US20170022266A1 (en) 2017-01-26
CY1124160T1 (el) 2022-05-27
EA201790763A2 (ru) 2017-07-31
NO2802624T3 (enExample) 2017-12-30
US20150011476A1 (en) 2015-01-08
HRP20210699T1 (hr) 2021-09-17
DK2802624T3 (da) 2017-11-13
EP2802624B1 (en) 2017-08-02
LT3536748T (lt) 2021-08-10
HRP20171635T1 (hr) 2018-02-23
RS56564B1 (sr) 2018-02-28
JP2019065017A (ja) 2019-04-25
HK1244296B (en) 2020-06-05
EP3901218A1 (en) 2021-10-27

Similar Documents

Publication Publication Date Title
HRP20210699T1 (hr) Izmijenjeni kolagen
NZ608432A (en) Gel composition
BR112013003045A2 (pt) composto e composição farmacêutica e respectivos usos, recipiente estéril e método para preparar composição farmacêutica para administração
MX354543B (es) Composicion esterilizada que comprende al menos un acido hialuronico y ascorbilo fosfato de magnesio.
NZ706361A (en) Nicotine composition
WO2013091775A3 (de) Verwendung von cyclohexanolderivaten als antimikrobielle wirkstoffe
WO2012143576A3 (en) Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
MX2013003635A (es) Compuestos de n-heteroarilo.
PH12015500738A1 (en) Shelf-stable, clear liquid nutritional compositions comprising epigallocatechin gallate (egcg) and methods for preparing the same
PH12015500763A1 (en) A frozen confection product and a method of preparing such
PH12012502329A1 (en) Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof
CA2920410C (en) Thienopiperidine derivative and use thereof
WO2012040804A3 (en) Synergistic combinations of triazoles, strobilurins and benzimidazoles, uses, formulations, production processes and applications using the same
WO2013177172A3 (en) Herpesvirus compositions and related methods
WO2015001163A3 (es) Nanopartículas lipídicas para la cicatrización de heridas
JP2015508403A5 (enExample)
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
MY169064A (en) Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same
ZA201500362B (en) Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
HK1222337A1 (zh) 用於施加药物活性成分或化妆品活性成分的局部组合物和载体
MX2016001422A (es) Composicion farmaceutica de fingolimod.
WO2013020719A3 (en) New use of compositions to delay the onset of the catagen phase of the hair
WO2012155226A8 (pt) Processo para a produção de derivados de pyrostegia venusta, derivados de pyrostegia venusta, composições farmacêuticas e seus usos
WO2016195194A3 (ko) 신규한 tlr2 길항제
HK1213806A1 (zh) 製造樹脂酊的方法